None
Quote | Medivir B (OTCMKTS:MVRBF)
Last: | $0.82 |
---|---|
Change Percent: | 0.0% |
Open: | $0.82 |
Close: | $0.82 |
High: | $0.82 |
Low: | $0.82 |
Volume: | 1,760 |
Last Trade Date Time: | 02/01/2023 09:30:39 am |
News | Medivir B (OTCMKTS:MVRBF)
2023-12-06 12:40:32 ET More on Medivir AB Historical earnings data for Medivir AB Financial information for Medivir AB For further details see: Medivir says IGM Biosciences cutbacks won't impact lead product fostrox
2023-08-18 14:38:37 ET More on Medivir AB Medivir starts dosing in mid-stage study of fostrox/Lenvima combo for liver cancer Infex's antibiotic MET-X gets FDA infectious disease product status Medivir's liver drug MIV-818 gets generic name fostroxacitabine bralpamide...
Message Board Posts | Medivir B (OTCMKTS:MVRBF)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Medivir Ser B Sek5 (MVRBF) Headlines Medivir: SVR12 Results from a Phase IIa S | Stock_Tracker | investorshangout | 03/10/2014 9:40:11 PM |
chartguy89: MVRBF 13.65 Stock Charts $MVRBF 1 Month Chart | chartguy89 | investorshangout | 03/08/2014 11:16:57 PM |
chartguy89: MVRBF Stock Charts Last: -0.28 Friday, February 28, 2014 at 4:05:39 AM $MVRBF 1 | chartguy89 | investorshangout | 02/28/2014 9:05:50 AM |
News, Short Squeeze, Breakout and More Instantly...
Medivir B Company Name:
MVRBF Stock Symbol:
OTCMKTS Market:
MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022 PR Newswire STOCKHOLM , Aug. 19, 2022 /PRNewswire/ -- The clinical development of fostrox remains the focus April - June Financial summary for the quarter Net turnover amoun...
Birinapant clinical study initiated by IGM Biosciences PR Newswire STOCKHOLM , Nov. 4, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR ) today announced that IGM Biosciences, Inc. has initiated its clinical study in solid cancers with birinapant (...
Medivir to present at the ProHearings shared Capital Markets Day PR Newswire STOCKHOLM , Oct. 11, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the ProHearings shared Capital Markets Day, Octo...